Cladribine, Cytarabine and Idarubicin in Patients With Relapsed Acute Myelocytic Leukemia (AML)
type: MedicalStudy
description: Phase II Study of Cladribine, High-dose Cytarabine and Idarubicin in Patients With Relapsed Acute Myeloid Leukemia
status: UNKNOWN
study design: INTERVENTIONAL
phase: PHASE2
start date: 2004-11
end date: 2011-03
license: https://creativecommons.org/publicdomain/zero/1.0/
source: https://clinicaltrials.gov/study/NCT00126321
source organization: US National Library of Medicine
publisher: AI Analytics
sponsor: University Hospital, Bonn
study subject: Leukemia, Myelocytic, Acute
keywords: PHASE2
keywords: INTERVENTIONAL
keywords: UNKNOWN
keywords: Leukemia, Myelocytic, Acute

AI Analytics
type: Organization